Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?

M Hingorani, WP Colley, S Dixit… - The British journal of …, 2012 - academic.oup.com
The prognosis of patients with glioblastoma (GBM) remains poor, and the use of
hyperfractionation or dose escalation beyond 60 Gy has not conferred any survival benefit …

Stereotactic radiosurgery and hypofractionated radiotherapy for glioblastoma

JL Shah, G Li, JL Shaffer, MI Azoulay, IC Gibbs… - …, 2018 - journals.lww.com
Glioblastoma is the most common primary brain tumor in adults. Standard therapy depends
on patient age and performance status but principally involves surgical resection followed by …

The radiosurgery fractionation quandary: single fraction or hypofractionation?

JP Kirkpatrick, SG Soltys, SS Lo, K Beal… - Neuro …, 2017 - academic.oup.com
Stereotactic radiosurgery (SRS), typically administered in a single session, is widely
employed to safely, efficiently, and effectively treat small intracranial lesions. However, for …

[HTML][HTML] The radiosensitivity index predicts for overall survival in glioblastoma

KA Ahmed, P Chinnaiyan, WJ Fulp, S Eschrich… - Oncotarget, 2015 - ncbi.nlm.nih.gov
We have previously developed a multigene expression model of tumor radiosensitivity (RSI)
with clinical validation in multiple cohorts and disease sites. We hypothesized RSI would …

A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas

R Shaffer, AM Nichol, E Vollans, M Fong… - International Journal of …, 2010 - Elsevier
PURPOSE: Volumetric modulated arc therapy (VMAT), the predecessor to Varian's
RapidArc, is a novel extension of intensity-modulated radiotherapy (IMRT) wherein the dose …

Central nervous system cancers, version 1.2015

LB Nabors, J Portnow, M Ammirati, J Baehring… - Journal of the National …, 2015 - jnccn.org
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Central Nervous
System (CNS) Cancers provide interdisciplinary recommendations for managing adult CNS …

Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma

A Omuro, K Beal, P Gutin, S Karimi, DD Correa… - Clinical Cancer …, 2014 - AACR
Purpose: Bevacizumab is associated with decreased vascular permeability that allows for
more aggressive radiotherapy schedules. We conducted a phase II trial in newly diagnosed …

Pattern of recurrence of glioblastoma versus grade 4 IDH-mutant astrocytoma following chemoradiation: A retrospective matched-cohort analysis

J Stewart, A Sahgal, AKM Chan… - … in Cancer Research …, 2022 - journals.sagepub.com
Background and Purpose: To quantitatively compare the recurrence patterns of glioblastoma
(isocitrate dehydrogenase-wild type) versus grade 4 isocitrate dehydrogenase-mutant …

Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues

D Amelio, S Lorentini, M Schwarz… - Radiotherapy and …, 2010 - Elsevier
Background and purpose: Intensity-modulated radiation therapy (IMRT) could represent a
new tool to improve the therapeutic ratio in the treatment of glioblastoma. This systematic …

Radiotherapy of glioblastoma 15 years after the landmark Stupp's trial: more controversies than standards?

T Kazda, A Dziacky, P Burkon, P Pospisil… - Radiology and …, 2018 - sciendo.com
Background. The current standard of care of glioblastoma, the most common primary brain
tumor in adults, has remained unchanged for over a decade. Nevertheless, some …